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Because of many recent diagnostic and therapeutic advances, malignant mel-
anoma has been receiving new notoriety. Nevertheless, it is far from a new disease.
Hippocrates (1) is credited with the first description ofthe lesion, which has always
been regarded with some fear and superstition. There was little contribution ofany
significance until the seventeenth century, when Highmore, Bartholin, and Bonet at
various times described the "fatal black tumor" (2). In 1806, Laennec and Du-
puytren independently published treatises on melanosis (1). Thirty years later, Cars-
well coined the term melanoma (1). Pemberton (3), in 1858, was the first to note the
significance of the regional lymph nodes and suggested lymphadenectomy. In 1868,
Langerhans (4) noted melanocytes in histologic specimens of skin as the "branched
cells," but it was not until 1951 that the term melanocyte was adopted. Wide
excision with regional node dissection was introduced by Handley (5) in 1907. This
concept was expanded by Pringle (6) the following year to include depth with the
primary excision. More recent advances are seen with the work ofCreech (7), who
introduced regional perfusion in 1958 by the use ofan extracorporeal circuit, and the
introduction ofimmunotherapy by Morton et al. (8)in 1970.
These historical milestones are summarized in Table 1 and may also be found,
along with a statistical review ofthe subject, in Knutson's monograph (9).
Current concepts of melanoma fall naturally into four broad areas: (i) diagnosis,
(ii) staging, (iii) surgery, and (iv) immunology. A symposium on melanoma was pre-
pared for Surgical Grand Rounds at Yale University in January of 1975, based on
such an outline.
The first paper deals with the clinical appearance of melanoma and some im-
portant points in the differential diagnosis of these lesions. Since there are an
average of 15 pigmented nevi per Caucasian, if 10,000 surgeons worked 8 hr/day
excising one nevus every 15 min, then the current population would be free ofnevi in
25 yr (Table 2). In order to avoid having to excise or biopsy every nevus, Dr. Nord-
lund presents the important features ofnevi that should make one suspicious ofthe
diagnosis of melanoma. In so doing, he discusses the first classification system that
differentiates melanomas by appearance: lentigo maligna (Hutchinson freckle),
superficial spreading, and nodular.
One of the most important advances in the study of melanoma has been the
recognition of the importance ofpathologic classification by depth, as first reported
by Clark (10). Dr. Smith, in the next paper in the series, describes this system and
discusses its relation to prognosis.
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TABLE 1
Summary of Historic Milestones in Melanoma
Hippocrates
Highmore
Bartholin
Bonet
Laennec
Dupuytren
Carswell
Pemberton
Langerhans
Handley
Pringle
Creech
Morton
First recorded description
Described "fatal black tumor"
Independently published treatises on melanosis
Coined the term melanoma
Suggested lymphadenectomy
Noted melanocytes ("branched cells")
Wide excision + RLND
Added depth + incontinuity RLND
Regional perfusion
Immunotherapy
TABLE 2
The Statistics of Excising All Pigmented Nevi
15, average per Caucasian
If 10,000 surgeons worked
8 hr per day excising
1 nevus every
15 min
Then the current population would be free of nevi in
25 yr
TABLE 3
How Melanoma Statistics May Be Biased
Statistics on melanoma are biased by
Who is reporting Where he is reporting from
Primary care physician Cancer center
Dermatologist University hospital
General surgeon City hospital
Plastic surgeon Community hospital
Chemotherapist HMO
Immunotherapist Industrial clinic
Pathologist
As well as country of origin, racial and sex predominance of the population, etc.
1651
1677
1679
1806
1806
1836
1858
1868
1907
1908
1958
1970
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In addition to describing the current thinking with regard to surgery in melanoma,
Dr. Arons points out that (i) melanoma is not a surgical emergency and (ii) inci-
sional biopsy is often the correct initial step in establishing a diagnosis. In his conclu-
sions, he states thegeneral consensus for the surgical approach to this disease.
In the final paper, Dr. Ariyan discusses the logic and the technique of the im-
munotherapy ofmelanoma.
A final word must be said about the statistics of melanoma. There has been
confusion and disagreement about many past conclusions concerning prognosis and
management, and each proponent has always proven his results by some series of
patients. Melanoma statistics, perhaps more than other malignancies, are biased by
who is reporting the study and where the report is originating. Table 3 lists these and
other features. Notwithstanding all the other difficulties oftreating this disease, the
discrepancies in the reports in the literature have often added to the confusion. By
examining the melanoma problem as it is currently understood from both the diag-
nostic and therapeutic approaches, this symposium was intended to present a logical
understanding ofthe disease from the viewpoint ofadermatologist, pathologist, sur-
geon, and immunotherapist.
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